Does EFALIZUMAB Cause Lung neoplasm malignant? 6 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Lung neoplasm malignant have been filed in association with EFALIZUMAB. This represents 2.6% of all adverse event reports for EFALIZUMAB.
6
Reports of Lung neoplasm malignant with EFALIZUMAB
2.6%
of all EFALIZUMAB reports
6
Deaths
3
Hospitalizations
How Dangerous Is Lung neoplasm malignant From EFALIZUMAB?
Of the 6 reports, 6 (100.0%) resulted in death, 3 (50.0%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFALIZUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does EFALIZUMAB Cause?
Death (56)
Psoriasis (55)
Pruritus (35)
Erythema (28)
Drug ineffective (26)
Pain (25)
Decreased appetite (24)
Hypersensitivity (24)
Vomiting (24)
Nausea (23)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which EFALIZUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
EFALIZUMAB vs EFANESOCTOCOG ALFA
EFALIZUMAB vs EFAVIRENZ
EFALIZUMAB vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
EFALIZUMAB vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
EFALIZUMAB vs EFFEXOR